colon cancer 2010
In this January 2010 supplement to Oncology, guest editor Axel Grothey from the Mayo Clinic, explores adjuvant therapy considerations in stage II colon cancer.
Risk Assessment in Stage II Colon Cancer
This supplement and associated publication costs were funded by Genomic Health.
In this January 2010 supplement to Oncology, guest editor Axel Grothey from the Mayo Clinic, explores adjuvant therapy considerations in stage II colon cancer.
Recent Videos
Related Content
Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care
Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO
March 10th 2025Podcast
Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.
